Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
I am no tax expert, however I have done some research in to the tax credit of HUR as it very significant imo.
I believe that the tax credit adds significant value to HUR and does not appear to be factored in to the mcap, it takes away almost all of the risk imo.
I believe that between 10m to 15m would be the value to a large oil company per 100m tax loss.
Given the mcap is only 98m, this is a huge insurance policy.
Imo the company could stop producing oil today and the value of this alone would cover a very significant amount of the 5p per share.
Or if HUR do indeed keep pumping oil at £300m a year, it's tax free which again is a huge benefit to the company and its shareholders.
To me the share price has completely ignored this and I can't understand how the company is trading at 5p a share which is a measly £98m mcap.
Haha you never know it's all too easy to ruffle some feathers on here.
Anyway after being sat down for not knowing, I stopped being lazy and had a fish around.
So still negotiating, but this doesn't look bad. Also imo it looks like we can build a very decent pot of cash before this point anyway.
Yes I bought a small amount during the court case, so i have not spent a lot of time on my due diligence with HUR. It was a gamble that came good for me.
I thought this would be a good friendly place to talk out the position and add to my understanding of the company.
With the price of oil it looks a good investment at this level, but there is plenty I am still learning.
Debts cleared and £50m in the bank and this looks like they could have no forward plan and at £98m mcap nobody would be out of pocket.
Zero downside and 100% upside.
When does the contract with FPSO currently come to an end?
E.g if we forget about any upside and forward planning, how long would we have to get the debt gone and 50m in the bank.
Don't get me wrong stocks are valued on forward antispiation but if cash + realistic value of tax credits = mcap then I find that an interesting position in itself.
I am trying to justify the £99m mcap
Let's assume tax credits have a market value of £15m for every £100m to a buyer.
What are the total tax credits worth at this value, is it about £45m?
I think a large portion of the mcap is secured by the £45m tax credit sale value alone.
It also is looking very likely that the debt will be gone and plus £50m will be in the bank in the 2nd half of this year.
Is the market just hyper sceptical after what has happened, or am I getting something wrong here?
Hi all,
With the price of oil in the current range, is it realistic / possible that HUR could take £300m worth of oil out of the ground this year?
I'm currently playing with the figures, am I well off the mark here ?
I like many expect it to fly up once the 5p resistance is finally broken.
Looks like we will find out now. Could be a very interesting few days.
gla
Both legalwolf and myself talked about this at the time.
The Nasdaq uses due bills so just because the entitlement has passed, it doesnt mean that buyers don't get that entitlement passed to them under the due bill process
https://www.investopedia.com/terms/d/duebill.asp
Good fine Blue! That's exactly what was discussed.
Posative news for tils imo
Only caught a snippet on sky just now. It appeared they were saying it's a very successful treatment based on 11k test patients over lots of companies trials and they urged world governments to help bring the costs down.
Can anybody find a clip?
GC always does a good interview but dropping this news on bloomberg later has got to attract a lot of interest. Welcome back GC
P.s vote now will GC dare drop the mothers milk line or is that ©? ™?
20 days ago there was an investor call where many milestones over the next few months were discussed. You should have been there there was some very exciting developments including imminent trials.
Davey & legalwolf
"I would suggest that everyone goes onto the Tiziana Life Sciences website and clicks on the Contact page, then sends a polite inquiry. "
6th of Jan I did this asking the two questions that legal wolf suggested.
Under the nasdaq "due bill" process it would mean that although the record date has passed the ex date hasn't.
So I asked the following questions:
1. If I sell my adr shares today which have been held over a year will I still get accustem shares as they were held past the record date?
2. If I buy adr shares today and keep them long term will I get accustem shares even though I have bought after the record date. If so why? Is this because of the due bill process on the nasdaq.
I followed up with several phone calls over a few weeks. When talking to them , they knew my email right away and said they didn't know the answer and they were investigating it. They said that the due bill process on the nasdaq made it much more complex than the uk traded share.
I also followed up with more emails chasing, I never received a single reply or acknowledgement.
In frustration I sent them a stronger email about 3 weeks ago saying that they really have to know themselves the answer to the questions, otherwise they are trading a stock that an investor can't value because even the company itself doesn't know, and continuing to trade a share in this manor breaches nasdaq rules as there can be no doubt the market is confused if the company itself is.
I do love the company but I do find all of this extremely poor.
Just got of the call.
Everything positive, my only concern is that the time frames may not please everyone. Certainly a lot more positive for long term biotech holders than short term traders, hopefully our shareholders base has now already flushed out the latter. Gla
Chins up people we need some posativity, if stocks didn't go up and down we wouldn't make any money.
This stock has bounced up and down a lot. Only in December it was over 20% lower than it is now, and by the start of Feb it was 75% higher than it is now.
It's natural to be down when the price is low, but how many times have you been kicking yourself that you didn't take the full opportunity the last time it was low after you watched it bounced back up like you knew it would.
I have a low average and I appreciate that it's not easy for people to be as rational if they have just come in at the recent high. But low averages are gained by buying in times like now, especially when it's proved time and time again it fly's back up.
Buy low sell high, and don't let a temporary price ruin your day.
GLA
SK you are as egar as me, I'm also trying to hover up and accumulate as many as possible. I am closing in on 1/2 million shares (if you're not already there, the challenge is on)
Getting some buys at 117 and even one at 116.4 it makes the low price a happy time doesn't it. Don't know about you but my eyes light up at this price.
Good to see the Nasdaq holding and refusing to follow us down.
When you say nothing has changed since march, where are we going to hide the 57m extra on the balance sheet?
Also you do lose any credibility you have when saying that Tiziana have tried to make a covid vaccine hahah. Come on mate anybody you hope to put off buying, or encourage selling is going to see right through you as we all know that Tiziana have never tried to make a covid vaccine as this isn't what the company does.
Tocilizumab works by blocking the effects of il-6 levels.
https://www.versusarthritis.org/about-arthritis/treatments/drugs/tocilizumab/
I was excited for Tziana when at the daily press conference tocilizumab was specifically mentioned due to the way it targets il-6 which is what 501 regulates.
This is great news for Tiziana imo, it's going to be a very interesting period for Tiziana.
Good upturn currently racing to 3% up on the day
No nerve hit there then lmao.
You have also just messed up in your drunken rage by pointing out I am actually invested in both.
Good night and enjoy your ban x